MYTIRAZ Trademark

Trademark Overview


On Friday, September 14, 2012, a trademark application was filed for MYTIRAZ with the United States Patent and Trademark Office. The USPTO has given the MYTIRAZ trademark a serial number of 85729516. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Thursday, October 10, 2013. This trademark is owned by Glaxo Group Limited. The MYTIRAZ trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the tre...
mytiraz

General Information


Serial Number85729516
Word MarkMYTIRAZ
Filing DateFriday, September 14, 2012
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateThursday, October 10, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2013

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Pseudo MarkMY TIRAZ

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, October 10, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events


Event DateEvent Description
Thursday, October 10, 2013ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Thursday, October 10, 2013ABANDONMENT - AFTER INTER PARTES DECISION
Thursday, October 10, 2013OPPOSITION TERMINATED NO. 999999
Thursday, October 10, 2013OPPOSITION DISMISSED NO. 999999
Tuesday, June 25, 2013OPPOSITION INSTITUTED NO. 999999
Thursday, March 28, 2013EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 26, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2013PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 22, 2013ELECTRONIC RECORD REVIEW COMPLETE
Friday, January 18, 2013ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, January 9, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 7, 2013ASSIGNED TO EXAMINER
Friday, September 21, 2012NOTICE OF PSEUDO MARK MAILED
Thursday, September 20, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 18, 2012NEW APPLICATION ENTERED IN TRAM